{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:26:53Z","timestamp":1761197213008,"version":"3.44.0"},"reference-count":30,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>Progressive multifocal leucoencephalopathy (PML) is a severe demyelinating disease of the central nervous system that is caused by the JC virus infection. It is often fatal or severely disabling. PML exclusively happens in the context of cell-mediated immunosuppression. Prior to the era of HIV, PML was mainly confined to patients with haematological malignancies and rheumatological diseases. The HIV epidemic in the early eighties led to massive expansion in the incidence and prevalence of the disease. PML has also been recognised to happen due to treatment with monoclonal antibodies such as natalizumab, which is used as a disease-modifying agent for relapsing remitting multiple sclerosis and other monoclonal antibodies used in dermatological and haematological conditions. The clinical picture is that of cognitive decline, visual disturbance and hemiparesis. The correct clinicoradiological picture combined with demonstrating the JC virus DNA in the cerebrospinal fluid (CSF) using PCR (PMR) is enough to establish the diagnosis. Brain biopsy is rarely needed. Immune reconstitution represents the mainstay in the treatment of PML. We present a case of a 47-year-old man who presented with progressive cerebellar ataxia. Investigations confirmed PML. He was found to be HIV positive. We also review the literature.<\/jats:p>","DOI":"10.1136\/bcr-2013-201619","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T06:03:31Z","timestamp":1385013811000},"page":"bcr2013201619","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Rapidly progressive cerebellar ataxia in West Wales"],"prefix":"10.1136","volume":"2013","author":[{"given":"Khalid","family":"Ali","sequence":"first","affiliation":[{"name":"Neurology Department, Morriston Hospital, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Amin","sequence":"additional","affiliation":[{"name":"Neurology Department, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathir G","family":"Yoganathan","sequence":"additional","affiliation":[{"name":"GUM\/HIV, ABM University Health Board, Singleton Hospital, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Powell","sequence":"additional","affiliation":[{"name":"Neurology Department, Morriston Hospital, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.1","first-page":"93","article-title":"Progressive multifocal leucoencephalopathy: a hitherto unrecognised complication of chronic lymphatic leukemia and Hodgkin's disease","volume":"2013","author":"Astrom","year":"1958","journal-title":"Brain"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"2013","author":"Padgett","year":"1971","journal-title":"Lancet"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virol.2008.09.027","article-title":"The role of polyomaviruses in human disease","volume":"2013","author":"Jiang","year":"2009","journal-title":"Virology"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.4","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","article-title":"Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases","volume":"2013","author":"Molloy","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.5","first-page":"1065","article-title":"Emerging viral infections of the central nervous system: part 2","volume":"2013","author":"Tyler","year":"2009","journal-title":"Arch Neurol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/infdis\/127.4.467","article-title":"Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy","volume":"2013","author":"Padgett","year":"1973","journal-title":"J Infect Dis"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"2013","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/514032","article-title":"Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy","volume":"2013","author":"Weber","year":"1997","journal-title":"J Infect Dis"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.21277","article-title":"Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma","volume":"2013","author":"Engels","year":"2005","journal-title":"Int J Cancer"},{"issue":"(Pt 6)","key":"2025082805061344000_2013.nov21_1.bcr2013201619.10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1099\/vir.0.18842-0","article-title":"Seroepidemiology of the human polyomaviruses","volume":"2013","author":"Stolt","year":"2003","journal-title":"J Gen Virol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"2013","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/JCM.38.1.105-109.2000","article-title":"Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus","volume":"2013","author":"Hamilton","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"2013","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"2013","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease","volume":"2013","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.16","unstructured":"Biogen Idec. New Tysabri data reaffirm substantial efficacy in treatment of people with MS and demonstrate stability of anti-JCV antibody status. Press release. http:\/\/www.biogenidec.com\/press_release_details.aspx?ID=5981&ReqId=1797077."},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.17","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV negative patients: a report of 57 cases from the research on adverse drug events and reports project","volume":"2013","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.18","first-page":"S271","article-title":"Fatal progressive multifocal leukoencephalopathy associated with efalizumab therapy: insights into the role of leukointegrin aLb2 in JC virus control","volume":"2013","author":"Schwab","year":"2009","journal-title":"Mult Scler"},{"issue":"(Suppl 2)","key":"2025082805061344000_2013.nov21_1.bcr2013201619.19","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.3949\/ccjm.78.s2.08","article-title":"Advances in the management of PML: focus on natalizumab","volume":"2013","author":"Fox","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"(Suppl 3)","key":"2025082805061344000_2013.nov21_1.bcr2013201619.20","doi-asserted-by":"crossref","first-page":"iii48","DOI":"10.1136\/ard.2006.058404","article-title":"Natalizumab and progressive multifocal leucoencephalopathy","volume":"2013","author":"Berger","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/practneurol-2011-000092","article-title":"Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring","volume":"2013","author":"Hunt","year":"2012","journal-title":"Pract Neurol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"2013","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy in HIV-1 infection","volume":"2013","author":"Cinque","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.24","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/art.22657","article-title":"Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease","volume":"2013","author":"Calabrese","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"(Suppl 2)","key":"2025082805061344000_2013.nov21_1.bcr2013201619.25","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.78.s2.03","article-title":"The clinical features of PML","volume":"2013","author":"Berger","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9343(99)80106-5","article-title":"AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures","volume":"2013","author":"Moulignier","year":"1995","journal-title":"Am J Med"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2214\/ajr.151.3.449","article-title":"CNS complications of AIDS: CT and MR findings","volume":"2013","author":"Ramsey","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.28","first-page":"597","article-title":"Progressive multifocal leukoencephalopathy: clinical and MR response to treatment","volume":"2013","author":"Garrels","year":"1996","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199701000-00003","article-title":"Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction","volume":"2013","author":"Cinque","year":"1997","journal-title":"AIDS"},{"key":"2025082805061344000_2013.nov21_1.bcr2013201619.30","first-page":"1","article-title":"Remission of progressive multifocal leucoencephalopathy following highly active antiretroviral therapy in a man with AIDS","volume":"2013","author":"Yoganathan","year":"2012","journal-title":"Int J Gen Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-201619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:06:28Z","timestamp":1756382788000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-201619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":30,"alternative-id":["10.1136\/bcr-2013-201619"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-201619","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}